SARS-CoV-2感染重症病例多器官病理实验室标志物及不良结局(系统评价)

Q4 Medicine
N. A. Konyshko, L. I. Volynets, G. S. Konyshko
{"title":"SARS-CoV-2感染重症病例多器官病理实验室标志物及不良结局(系统评价)","authors":"N. A. Konyshko, L. I. Volynets, G. S. Konyshko","doi":"10.22625/2072-6732-2023-15-3-29-38","DOIUrl":null,"url":null,"abstract":"The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.","PeriodicalId":52123,"journal":{"name":"Jurnal Infektologii","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Laboratory markers of multiple organ pathology in severe cases and adverse outcomes of SARS-CoV-2 infection (systematic review)\",\"authors\":\"N. A. Konyshko, L. I. Volynets, G. S. Konyshko\",\"doi\":\"10.22625/2072-6732-2023-15-3-29-38\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.\",\"PeriodicalId\":52123,\"journal\":{\"name\":\"Jurnal Infektologii\",\"volume\":\"29 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Infektologii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22625/2072-6732-2023-15-3-29-38\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Infektologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22625/2072-6732-2023-15-3-29-38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

该综述的目的是:提供与严重SARS-CoV-2感染和内脏损伤相关的患者实验室参数的最新科学信息。材料和方法:分析2019年至2022年期间来自PubMed、Elsevier、Scopus、Google Scholar、E-library等科学数据库的临床、随机和队列研究全文、系统评价和荟萃分析。结果。确定了特异性生物标志物,包括炎症和免疫参数(c反应蛋白、降钙素原、IL6)、血液学参数(淋巴细胞和中性粒细胞数量、NLR、d -二聚体、铁蛋白、RDW)、心肌参数(肌钙蛋白、肌动激酶mb、肌红蛋白)、肝脏参数(AST、ALT、总胆红素、白蛋白)和肺损伤特征(KL-6),这些可用于风险分层,作为COVID-19患者不良临床后果(包括死亡)的预后生物标志物。这些研究发现了covid - 19炎症和全身表现的新生物标志物:降钙素原、钙保护素和高血压素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Laboratory markers of multiple organ pathology in severe cases and adverse outcomes of SARS-CoV-2 infection (systematic review)
The aim of the review: to present up-to-date scientifically based information about the laboratory parameters of patients associated with severe SARS-CoV-2 infection and internal organ damage. Materials and methods: full-text publications of clinical, randomized and cohort studies, systematic reviews and meta-analyses from scientific databases PubMed, Elsevier, Scopus, Google Scholar, E-library for the period from 2019 to 2022 were analyzed. Results. Specific biomarkers were identified, including inflammatory and immunological parameters (C-reactive protein, procalcitonin, IL6), hematological (number of lymphocytes and neutrophils, NLR, D-dimer, ferritin, RDW), myocardial (troponin, creatinekinase-MB, myoglobin), hepatic (AST, ALT, total bilirubin, albumin) and characterizing lung injury (KL-6), which can be used for risk stratification, as prognostic biomarkers of adverse clinical consequences, including death in patients with COVID-19. The studies demonstrated new biomarkers of inflammatory and systemic manifestations of COVID19: procalcitonin, calprotectin and presepsin.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Jurnal Infektologii
Jurnal Infektologii Medicine-Infectious Diseases
CiteScore
0.80
自引率
0.00%
发文量
52
审稿时长
8 weeks
期刊介绍: The purposes of the journal are to describe modern achievements in the study of infectious diseases, and in related sciences as well; to promote the exchange of clinical experience among the experts; to publish the results of clinical research of medical products and medical equipment; to give the information on medical congresses on infectious diseases as well as other significant events in the field of modern infectology in our country and abroad.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信